TY  - JOUR
T1  - Behavioral medicine trial design: Time for a change—reply
AU  - Berkowitz SA, Johansen KL
Y1  - 2012/09/24
N1  - 10.1001/archinternmed.2012.3223
JO  - Archives of Internal Medicine
SP  - 1350
EP  - 1351
VL  - 172
IS  - 17
N2  - 
We wish to thank Lavoie and colleagues for their thoughtful letter. We agree with their suggestion that interventions in behavioral medicine be viewed analogously to phase 1, 2, and 3 clinical trials in drug development and thank them for pointing out the recommendations of the Office of Behavioral and Social Science Research.

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2012.3223
UR  - http://dx.doi.org/10.1001/archinternmed.2012.3223
ER  -